⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Consult your healthcare provider before starting any medication.
GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro) — interact with several medications commonly prescribed in India. Understanding these interactions can prevent dangerous situations ranging from hypoglycaemia (low blood sugar) to medication failure to serious organ stress.
This guide covers the most clinically significant drug interactions relevant to Indian patients, including interactions with diabetes medications, blood pressure drugs, cholesterol medications, thyroid drugs, and commonly used supplements. It is written for patient education — always share your complete medication list with your prescribing doctor.
GLP-1 receptor agonists work partly by slowing gastric emptying — food (and medication) moves through your stomach more slowly. This has a crucial pharmacological consequence: any oral medication you take may be absorbed more slowly and at different concentrations than expected.
This matters especially for:
Risk: Hypoglycaemia (dangerously low blood sugar)
This is the most dangerous and most common interaction in India's large diabetes patient population.
Drugs affected: All insulin types (regular, NPH, glargine, detemir, aspart, lispro), Glibenclamide (Daonil), Glipizide, Gliclazide (Diamicron), Glimepiride (Amaryl), Glucored Forte
What happens: GLP-1 medications significantly lower blood glucose. When combined with insulin or sulfonylureas — which also independently lower blood glucose — the combined effect can push blood sugar dangerously low (below 70 mg/dL). This is hypoglycaemia.
Symptoms of hypoglycaemia: Sudden sweating, trembling, heart pounding, confusion, dizziness, sudden weakness. Severe cases cause unconsciousness.
What to do:
Note on Metformin: Metformin alone does not cause hypoglycaemia and is safe to continue with GLP-1 therapy. The metformin + GLP-1 combination is widely prescribed and well-tolerated.
Risk: Reduced contraceptive efficacy
Drugs affected: Yasmin, Diane-35, Femilon, Ovral-L, Mala-N, Unwanted-21, and all combined OCP formulations
What happens: Slowed gastric emptying caused by GLP-1 medications can delay OCP absorption. If a pill is not absorbed at the expected rate, contraceptive efficacy may be temporarily reduced — particularly during the first weeks of GLP-1 therapy.
Novo Nordisk guidance (semaglutide): Take oral contraceptives at least 1 hour before the semaglutide injection day, or consider switching to non-oral contraception for the first injection cycle.
What to do:
Risk: Under-absorption leading to undertreated hypothyroidism
Drugs affected: Thyronorm, Eltroxin, Thyrox (all levothyroxine sodium formulations)
What happens: Levothyroxine is one of the most absorption-sensitive medications available. It must be taken on an empty stomach, 30–60 minutes before food or other medication. GLP-1-induced delayed gastric emptying may reduce levothyroxine absorption — leading to rising TSH and undertreated hypothyroidism.
Signs of undertreated hypothyroidism: Weight gain (counterproductive to GLP-1 goals), fatigue, cold intolerance, dry skin, constipation, elevated TSH on blood tests.
What to do:
Risk: INR fluctuations causing bleeding or clotting
Drugs affected: Warfarin (Warf, Uniwarfin), Acenocoumarol (Acitrom)
What happens: GLP-1-induced weight loss and dietary changes (eating fewer vitamin K-containing green vegetables) can alter INR readings. Fluctuating INR increases risk of either dangerous bleeding or clotting events.
What to do:
Risk: Kidney stress and worsened gastrointestinal side effects
Drugs affected: Ibuprofen (Brufen, Combiflam), Diclofenac (Voveran, Voltaren), Nimesulide (Nicip, Nise), Naproxen
What happens: NSAIDs reduce blood flow to the kidneys. GLP-1 medications can cause dehydration through nausea and reduced fluid intake — which compounds NSAID-related kidney stress. NSAIDs also significantly worsen GLP-1-induced nausea and can trigger gastrointestinal bleeding in susceptible individuals.
What to do:
Risk: Additive muscle side effects; monitoring needed
Drugs affected: Atorvastatin (Atorva, Lipitor), Rosuvastatin (Crestor, Rosulip), Simvastatin
What happens: Both statins and GLP-1 medications can rarely cause myalgia (muscle pain) or weakness. Using both simultaneously requires awareness of this overlapping side effect. On the positive side, GLP-1 therapy often improves lipid profiles — which may allow statin dose reduction over time.
What to do:
Many Indian patients use Ayurvedic or herbal supplements without informing their doctors, assuming they are safe because they are "natural." Several common supplements have pharmacological activity that interacts with GLP-1 medications:
| Supplement | Common Use | Interaction Risk |
|---|---|---|
| Karela (bitter gourd) extract | Blood sugar lowering | Additive hypoglycaemia with GLP-1 + insulin |
| Methi (fenugreek) seeds | Blood sugar, digestion | Mild additive glucose-lowering effect |
| Gurmar (Gymnema sylvestre) | Blood sugar | Can cause hypoglycaemia with GLP-1 |
| Ashwagandha | Stress, energy | May interact with thyroid medications |
| Triphala | Digestion, laxative | May worsen GLP-1 diarrhoea |
| Ginseng | Energy, immunity | May alter blood glucose unpredictably |
What to do: List every supplement — Ayurvedic, homeopathic, and over-the-counter — when speaking with your doctor. A supplement causing hypoglycaemia can be just as dangerous as a prescription medication doing the same.
1. Not informing all specialists: Many patients see an endocrinologist for GLP-1, a cardiologist for heart medication, a gynaecologist for OCP — without informing each doctor about the others' prescriptions. Always carry a written list of ALL your current medications to every appointment.
2. Self-adjusting insulin: Blood sugar can drop significantly in the first weeks of combined GLP-1 + insulin therapy. Do not self-adjust — call your doctor immediately if blood sugar is consistently below 80 mg/dL.
3. Not disclosing Ayurvedic supplements: Karela and Gurmar tablets are freely sold at Indian pharmacies and chemist shops. Adding them to GLP-1 + insulin therapy without medical supervision can cause dangerous hypoglycaemia.
4. Taking all medications at the same time: Levothyroxine, metformin, and GLP-1 injections each have optimal timing. Ask your doctor for a medication schedule.
The following medications are commonly prescribed alongside GLP-1 therapy without significant interaction concerns:
Go to your nearest emergency department or contact your doctor immediately if:
Q: Can I take GLP-1 with metformin and an SGLT-2 inhibitor together? Yes. The triple combination of metformin + SGLT-2 inhibitor + GLP-1 is increasingly standard in India's type 2 diabetes management guidelines. Discuss the specific combination with your endocrinologist.
Q: Do I need to adjust my blood pressure medication when starting GLP-1? GLP-1 medications can lower blood pressure as weight decreases. If you are on antihypertensives (Amlodipine, Telmisartan, Ramipril), your doctor may reduce your dose over time — but do not adjust without medical guidance.
Q: Are there any medications that make GLP-1 work better? Not directly. However, metformin and SGLT-2 inhibitors both address different aspects of type 2 diabetes and obesity — using them together with GLP-1 often produces better outcomes than any medication alone.
This article is for informational purposes only. Consult your healthcare provider before starting any medication or making changes to your current medication regimen. Always share your complete medication list with all your treating doctors.